Ms. Kang has been involved in developing GMP-based cellular therapeutic products in the bio-pharmaceutical industry for over 16 years. Prior to working for NKMAX Korea, she served as the general manager of quality control/assurance/manufacturing for Pharmicell Co., Ltd where she played an important role in obtaining the product license of the first commercially available stem cell therapy in Korea. She earned her B.S and M.S degree in Biology from Kongju National University in Korea.